Integrated Healing Technologies LLC

Integrated Healing Technologies, LLC develops negative pressure wound therapy devices and systems. The company offers PhaseOne, a pure hypochlorous solution; Cutimed Sorbact, a woven acetate mesh that is coated with a fatty acid ester dialkylcarbamoylchloride; and NewEraI, a negative pressure pump. It also provides NewEraII, a negative pressure wound therapy pump used to help treat non-healing wounds; drainage systems; and dressing kits. The company serves hospitals, long term care facilities, specialty wound care clinics, nursing homes, home health care, and durable medical equipment providers in the United States. Integrated Healing Technologies, LLC has strategic relationships with Healthtrust Purchasing Group, L.P., ABIGO Medical AB, BSN medical, Lescarden Incorporated, Premier, Medline, NovaBay Pharmaceuticals, CSI Medical, Inc., and Wound, Ostomy and Continence Nurses Society. Integrated Healing Technologies, LLC was formerly known as Pioneer Technology, LLC. The company was incorporated in 2007 and is based in Franklin, Tennessee.

Check out our last patent-backed bankruptcy report: Guided Systems Technologies

Patent-Backed Bankruptcy Report Archive

 

Address

103 Forrest Dr

Franklin, TN 37064

United States

 

ihtwoundcare.com

Ownership

Private

Industry

Hospital Equipment and Supplies

Integrated Healing Technologies Debt-Asset Leverage Estimate

Chapter Type Case Number Assets Liabilities Industry/Description
7 18-04526 $1 – 10 Million $10 – 50 Million Hospital Equipment and Supplies
Portfolio Valuation Range Asset Valuation Range Total Assets Valuation Range Liability Range Leverage Ratio Range
 $125,000 – 1,035,000  $500,000 – $10,000,000  $625,000 – $11,035,000  $5,000,000 – $37,500,000  0.1667 – 2.207


Patent Portfolio

15 assets

  • 8 U.S. Assets
  • 2 Canadian Assets
  • 2 European Assets

Integrated Healing Tech Portfolio Summary

  1. US7648488 B2

Title: Wound care system

Abstract: Disclosed is an apparatus for the treatment of a wound on a patient. The apparatus is capable of administering localized negative pressure therapy to the wound using a negative pressure source and a drain line for removing exudate from the wound. The apparatus is also capable of administering localized hyperbaric fluid therapy to the wound using a fluid source and a supply line for supplying fluid to the wound.

First Claim: 

A wound treatment apparatus comprising:

a drain line configured for attachment to a negative pressure source and for removing exudate from the wound;

a supply line configured for attachment to a fluid source and for supplying fluid to the wound;

a controller configured to:

cause negative pressure therapy to be administered to the wound via the drain line, and cause hyperbaric fluid therapy to be administered to the wound via the supply line for approximately 10 seconds to approximately 60 seconds; and

a dressing to cover the wound and engage the supply line and the drain line, wherein the dressing comprises a pliable adhesive material molded onto the patient’s skin around the perimeter of the wound to form a gasket between the patient’s skin and a sealing material opposite the skin.

2. US 8357130 B2

Title: Wound care apparatus

Abstract: Disclosed is an apparatus for the treatment of a wound on a patient. The apparatus is capable of administering localized negative pressure therapy to the wound using a hospital wall vacuum source and a drain line for removing exudate from the wound. The apparatus may also be capable of administering localized hyperbaric oxygen therapy to the wound using a hospital wall oxygen source and a supply line for supplying oxygen to the wound. The apparatus includes at least one regulator to control the application of negative pressure therapy and hyperbaric oxygen therapy.

First Claim:

A method for treating a wound comprising:

connecting the supply line to a pressure regulator connected to a hospital wall oxygen line associated with a hospital line oxygen source regulating the pressure applied to the wound via the drain line such that the pressure applied to the wound is greater than the hospital line negative pressure;

regulating the pressure applied to the wound via the supply line such that the pressure applied to the wound is less than the hospital wall oxygen line pressure;

administering hyperbaric fluid therapy to the wound via the supply line for approximately 10 seconds to approximately 60 seconds; and

administering negative pressure therapy to the wound via the drain line at less than 1 atmosphere for approximately 20 seconds to approximately 180 seconds;

wherein the hyperbaric oxygen therapy and the negative pressure therapy are administered intermittently such that negative pressure therapy is administered immediately following the administration of hyperbaric oxygen therapy and hyperbaric oxygen therapy is administered immediately following the administration of negative pressure therapy.

Portfolio Valuation

IPVal offers portfolio valuation services.